Skip to main content
. Author manuscript; available in PMC: 2012 Jul 12.
Published in final edited form as: Transplant Proc. 2010 Sep;42(7):2702–2706. doi: 10.1016/j.transproceed.2010.05.155

Table 2.

Crude and Multivariate Analysis

GERD (n = 33) (95% CI) No GERD (n = 27) (95% CI) P Value
Median # of ARE 1 (0–3) 0 (0–1)
Episodes of ARE 39 12
# of surveillance TBBs 126 113
Patient-days 4,593 4,656
Incidence density (1,000 patient-days) 8.49 (6.03–11.61) 2.58 (1.33–4.50) .00016
Crude incidence density ratio 3.29 .00016
Adjusted* incidence density ratio 2.15 .009

Abbreviations: ARE, acute rejection episodes; TBB, transbronchial biopsy; others as in Table 1.

*

GERD, recipient CMV status, and use of basiliximab and tacrolimus were identified to have significant effects by univariate analysis and were used for multivariate analysis by negative binomial method.